M Erkan

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi request reprint Tumor microenvironment and progression of pancreatic cancer
    M Erkan
    Department of Surgery, Technische Universitat Munchen, Ismaningerstrasse 22, Munich 81675, Germany
    Exp Oncol 32:128-31. 2010
  2. pmc Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
    Mert Erkan
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Mol Cancer 9:88. 2010
  3. doi request reprint AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
    B Kong
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Oncogene 29:5146-58. 2010
  4. pmc Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
    C W Michalski
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Br J Cancer 99:760-7. 2008
  5. doi request reprint Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    K Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munich, Germany
    Eur J Nucl Med Mol Imaging 39:846-51. 2012

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Tumor microenvironment and progression of pancreatic cancer
    M Erkan
    Department of Surgery, Technische Universitat Munchen, Ismaningerstrasse 22, Munich 81675, Germany
    Exp Oncol 32:128-31. 2010
    ..The common denominator of all these conditions is; chronic inflammation leads to increased incidence of cancer. In this review the impact of the activated stroma on pancreatic carcinogenesis is discussed...
  2. pmc Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
    Mert Erkan
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Mol Cancer 9:88. 2010
    ..To identify organ- and disease-specific stellate cell transcriptional fingerprints, we employed genome-wide transcriptional analysis of primary human PSC and HSC isolated from patients with chronic inflammation or cancer...
  3. doi request reprint AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
    B Kong
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Oncogene 29:5146-58. 2010
    ..Thus, epigenetically regulated ZAG is a novel tumor suppressor essential for maintaining an epithelial phenotype...
  4. pmc Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
    C W Michalski
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Br J Cancer 99:760-7. 2008
    ..This suggests that ATP-TCA testing could be used as a decision-making tool in the adjuvant treatment of pancreatic cancer...
  5. doi request reprint Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    K Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munich, Germany
    Eur J Nucl Med Mol Imaging 39:846-51. 2012
    ....